説明
Patient-reported global satisfaction with treatment outcomes is compared between the synbiotic and placebo groups.
Figure 15
ChartSource Paper
The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidobacterium Probiotic Strains and Short Chain Fructooligosaccharides in Patients with Diarrhea Predominant …Cite This Figure
![Figure 15: Patient-reported global satisfaction with treatment outcomes is compared between the synbiotic and placebo groups.]() > Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." *Nutrients*, 2020. PMID: [32635661](https://pubmed.ncbi.nlm.nih.gov/32635661/)
<figure> <img src="" alt="Patient-reported global satisfaction with treatment outcomes is compared between the synbiotic and placebo groups." /> <figcaption>Figure 15. Patient-reported global satisfaction with treatment outcomes is compared between the synbiotic and placebo groups.<br> Source: Barbara Skrzydło-Radomańska et al. "The Effectiveness of Synbiotic Preparation Containing Lactobacillus and Bifidoba." <em>Nutrients</em>, 2020. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/32635661/">32635661</a></figcaption> </figure>
関連するエビデンス
B
Bifidobacterium longum : Irritable Bowel Syndrome (IBS)
B
グレード B · 4 件の研究
Galactooligosaccharides (GOS) : Irritable Bowel Syndrome (IBS)
B
グレード B · 3 件の研究
Lactobacillus acidophilus : Irritable Bowel Syndrome (IBS)
D
グレード B · 3 件の研究
Fructooligosaccharides (FOS) : Irritable Bowel Syndrome (IBS)
グレード D · 2 件の研究